Central and peripheral alytesin cause short-term anorexigenic effects in neonatal chicks.
We studied the effects of alytesin, a natural analogue of bombesin, on appetite-related responses and behaviors in neonatal chicks. Chicks responded to both intracerebroventricular (ICV) and peripheral injections of alytesin with short-term reduced feed intake. ICV alytesin caused reduced short-term water intake when feed was present, but we determined this effect was secondary to feed intake since an effect on water intake was not detected in feed-restricted alytesin-treated chicks. The anorexigenic effect of both ICV and peripheral alytesin may be mediated at the hypothalamus, since all hypothalamic nuclei studied; regio lateralis hypothalami, nucleus dorsomedialis hypothalami, nucleus paraventricularis magnocellularis, nucleus perventricularis hypothalami, nucleus infundibuli hypothalami and the nucleus ventromedialis hypothalami, were activated as evident by increased c-Fos immunoreactivity. Central alytesin did not cause increased behaviors that were unrelated to ingestion and did not cause anxiety-related behavior patterns. Additionally, central alytesin did not affect pecking efficacy. We conclude that both ICV and peripheral alytesin injections induce anorexigenic effects in chicks, and the hypothalamus is involved. While the anorexigenic effects of alytesin and bombesin appear to be conserved across species, the two peptides may differ in other behavioral responses and central mechanisms of action.
Cline
Mark A
MA
Department of Biology (6931), Radford University, Radford, VA 24142, USA. mcline@radford.edu
Fouse
Dawn N
DN
Prall
Brian C
BC
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001066:Appetite / Q000187:drug effects; D001067:Appetite Depressants; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology*; D002645:Chickens / Q000502:physiology*; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D007150:Immunohistochemistry; D007267:Injections; D007276:Injections, Intraventricular; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology*; D010525:Peripheral Nerves; D017933:Peripheral Nervous System / Q000187:drug effects / Q000502:physiology*; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis / Q000378:metabolism
D001067:Appetite Depressants; D010455:Peptides; D016760:Proto-Oncogene Proteins c-fos; C000058:alytesin